Webinar – Compound adsorption by different biochip materials

Organ-on-chip technology has enormous potential to shape the future of drug discovery and development. Simulating the physiology of human organs and tissues on a biochip reproduces the key functions and responses of these in a “mini-version.”  These in vivo-like systems can bridge the gap between animal testing and human trials, and thereby enable better dosage prediction in preclinical research. However, choice of the right biochips for organ models is critical. Depending on the biochip materials used, dosage prediction might be hampered through high compound adsorption rates and nutritional misbalance caused by the material itself.